ARTV
Artiva Biotherapeutics, Inc.
There isn't enough reported data to score ARTV yet.
ARTV Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
ARTV's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
ARTV PE Valuation
ARTV has no meaningful PE right now: it lost money over the past year.
ARTV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| Moderate |
Analysts expect ARTV's losses to shrink, with revenue holding steady.
ARTV Earnings Per Share
ARTV lost $2.99 per share over the past year, a bigger loss than the year before.
ARTV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2024 | $251K | -75% |
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2024 | -5774% | -3985 points |
| Q4 2023 | -509% | N/A |
| Q3 2023 | 41% | N/A |
| Q2 2023 | -338% | N/A |
| Q1 2023 | -1788% | N/A |
ARTV's operating margin was −5774% last quarter, down 3985 points from the same quarter a year ago, near the bottom of its range since 2023.
ARTV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$29.5M | -$9.7M |
| Q2 2026 | -$20.8M | +$3.3M |
| Q1 2026 | -$21.2M | -$840K |
| Q4 2025 | -$15.1M | -$433K |
| Q3 2025 | -$19.8M | -$8.1M |
| Q1 2025 | -$20.4M | -$5.2M |
| Q4 2024 | -$14.7M | -$3.4M |
| Q3 2024 | -$11.7M | -$780K |
ARTV has burned cash in almost every quarter: −$87M over the past year, against −$79M the year before.
ARTV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +30% | +11.8M shares |
| 1 year | +109% | +26.7M shares |
| 3 years | +191% | +33.6M shares |
ARTV has 51M diluted shares, up 109% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $12,000 |
ARTV Net Leverage
ARTV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARTV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.2 | Neutral |
| Stochastic | 1.5 | Oversold |
ARTV's weekly RSI is 30 (neutral) and its Stochastic is 1 (oversold).
ARTV PE vs Healthcare Sector
ARTV has no meaningful PE right now: it lost money over the past year.
ARTV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.63 | 30% below |
| 20 week MA | $8.45 | 53% below |
| 50 week MA | $7.32 | 46% below |
| 100 week MA | $5.57 | 29% below |
ARTV is in a downtrend: it's below all four of its weekly moving averages, and 29% below its 100-week average.
ARTV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $12.0 | $10.6 | -11% |
| 2025 | $10.6 | $4.18 | -61% |
| 2026 YTD | $4.18 | $3.96 | -5.3% |
ARTV has finished every year since 2024 lower, and it's down 5.3% so far in 2026.